Control X-Medical

Control X-Medical

Budapest, Hungary· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Control-X Medical is a well-established, privately-held Hungarian company specializing in the design and manufacture of diagnostic X-ray systems for both human and veterinary medicine. With 35 years of experience, it has built a significant international presence, leveraging a flexible product portfolio and a global distributor network to serve diverse market needs. The company focuses on delivering robust, configurable imaging solutions with a low total cost of ownership, supported by a strong commitment to quality and regulatory compliance (ISO, CE, FDA). Its operations are centered at its nearly zero-carbon headquarters in Dunakeszi, Hungary.

Medical DevicesDiagnostics

Technology Platform

Design and manufacture of configurable diagnostic X-ray systems for digital radiography, including ceiling-mounted, floor-mounted, and mobile units for medical and veterinary use.

Opportunities

Growing demand for cost-effective and flexible digital X-ray systems in emerging markets and the expanding veterinary care sector presents significant growth potential.
The company's EU-based manufacturing and compliance with major global regulations (CE, FDA) provide a strong foundation for international expansion and competitiveness.

Risk Factors

Intense competition from large multinational corporations and other low-cost manufacturers pressures margins and market share.
Evolving medical device regulations (like EU MDR) require continuous investment in compliance and pose a barrier to market entry if certifications are delayed or denied.

Competitive Landscape

Operates in a crowded market dominated by giants like Siemens, GE, and Philips, competing on flexibility, reliability, and cost rather than technological breakthrough. Also faces competition from numerous regional manufacturers, particularly in price-sensitive markets.